Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British…

By W. Dixon, K. Watson, M. Lunt, K. Hyrich, A. Silman, D. Symmons. Arthritis & Rheumatism, 2006

761 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Rheumatology

View Paper: https://www.semanticscholar.org/paper/5195173a91276c54c096ca2d4999992b96f907dc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Rheumatology

1. D. Tracey
2. Lars Klareskog
3. J. Salfeld
4. P. Tak
5. E. Sasso

Citations in the corpus

• Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. (2008, result): “…(Listing et al., 2005; Bongartz et al., 2006; Askling et al., 2007), but some studies have found there is no overall increased risk for infections after TNF blockade as compared with the frequency in patients with RA not treated with TNF antagonists (Dixon et al., 2006; Schiff et al., 2006a).”